Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 657 of 6351
-
New biologic drug aims to cut COPD attacks in half
Disease control Recruiting nowA Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for nigerian women with aggressive breast cancer: targeted drug combo under study
Disease control Recruiting nowDoctors leading this study would like to learn about providing cancer treatment/therapies to Nigerian women with breast cancer based on their human epidermal growth factor receptor 2 (HER2) status. This study will focus on the efficacy and safety of anti-HER2 cancer treatment bef…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study aims to wipe out aggressive breast cancer before surgery
Disease control Recruiting nowThe primary purpose of this study is to determine what proportion of participants will achieve complete pathological response with epirubicin+ cyclophosphamide followed by docetaxel +carboplatin. This will also examine the potential of using signals in the blood (biomarkers) to i…
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Liver cancer trial tests immunotherapy plus chemo combo
Disease control Recruiting nowTo evaluate HAIC combined with Sintilimab plus bevacizumab biosimilar for advanced hepatocellular carcinoma.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could less radiation be just as good for some throat cancers?
Disease control Recruiting nowThis clinical trial tests the effect of induction chemotherapy response-guided radiation (de-escalated intensity-modulated radiation therapy \[IMRT\]) compared to standard IMRT in patients with Epstein-Barr virus (EBV)-associated nasopharyngeal cancer. Intensity-modulated radiati…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Obesity drug may ignite 'Brown Fat' to torch calories
Disease control CompletedThis study is testing whether a new anti-obesity medicine called tirzepatide can increase the activity of special fat cells in the body that help burn energy. These fat cells are known as brown and beige fat. The study includes women with obesity and will last 24 weeks. Particip…
Phase 2 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can remote glucose monitoring tame type 2 diabetes in underserved communities?
Disease control OngoingThe goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled…
Sponsor: Diabetes Solutions International • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Brain training tailored to deficits may curb relapse and crime
Disease control Recruiting nowThe goal of this clinical trial is to investigate the effect of two types of cognitive remediation training on real-world behavioral outcomes including substance use, institutional adjustment, and recidivism following release from prison. Each training type is designed to target …
Sponsor: The Mind Research Network • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New trial matches cancer patients to smart drug bombs
Disease control Recruiting nowThis phase II ADC MATCH screening and multi-sub-study treatment trial is evaluating whether biomarker-directed treatment with one of three antibody-drug conjugates (ADCs) (sacituzumab govitecan, enfortumab vedotin, and trastuzumab deruxtecan) works in treating patients with solid…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug cocktail aims to tackle returning myeloma
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects, and best dose of iberdomide and how well it works in combination with daratumumab, elotuzumab, and dexamethasone in treating patients with multiple myeloma that has come back after a period of improvement (relapsed). Immunothe…
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for recurrent ovarian cancer: targeted drug combo enters human trials
Disease control Recruiting nowThe objective is to evaluate the tolerance, safety, pharmacokinetic characteristics and immunogenicity of SHR-A1811 combined with carboplatin and bevacizumab in the treatment of platinum sensitive recurrent epithelial ovarian cancer, and to determine the RP2D of the combination, …
Phase 1/2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug IMVT-1402 aims to stop CIDP relapses in Mid-Stage trial
Disease control Recruiting nowThis is a Phase 2b study to evaluate the efficacy and safety of Imeroprubart in adults with CIDP.
Phase 2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Drones to the rescue: flying HIV meds to Uganda's islands
Disease control Recruiting nowThe goal of this clinical trial is to learn if the intervention of delivery of antiretroviral drugs by medical drones can improve virological suppression in a fisherfolk community population living with HIV in the islands of Kalangala District, Uganda. The main question it aims t…
Sponsor: Makerere University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Brain cancer breakthrough? new immunotherapy combo targets recurrent glioblastoma
Disease control Recruiting nowThe purpose of this study is to assess the safety and efficacy of the combination of D2C7-IT+2141-V11 administered in the non-enhancing tumor of patients with resected recurrent glioblastoma (rGBM) via convection enhanced delivery (CED), followed by subcutaneous cervical perilymp…
Phase 1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Wearable device could simplify multiple myeloma treatment
Disease control Recruiting nowThe primary purpose of this study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatuximab in combination with weekly carfilzomib and dexamethasone (Kd) in adult participants with RRMM having received 1 to 3 prior lin…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New knee implant aims to repair cartilage and ease pain
Disease control Recruiting nowThe goal of this randomized controlled clinical trial is to demonstrate the safety and effectiveness of the BioPoly® Partial Resurfacing Knee Implant for the treatment of cartilage defects of the distal femur in adult patients with knee pain and symptoms who are candidates for su…
Sponsor: BioPoly LLC • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
A personalized lifeline: can Stepped-Care in the ER keep suicidal youth engaged in treatment?
Disease control Recruiting nowThe goal of this study is to develop a feasible brief, family-based adaptive intervention, via SMART design, for youth with suicidal and non-suicidal self-injurious behavior (SSIB) to increase community-based mental health (MH) care attendance and reduce SSIB risk post emergency …
Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New shot helps diabetics shed pounds in major trial
Disease control OngoingThe primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a tiny device speed up cancer diagnosis for people with HIV?
Diagnosis Recruiting nowPersons living with HIV (PLWH) in sub-Saharan Africa (SSA), lymphadenopathy often portends one of a number of life-threatening diseases including tuberculosis, lymphoma, and multicentric Castleman disease (MCD). Overcoming these delays and missed diagnoses requires new approaches…
Sponsor: Indiana University • Aim: Diagnosis
Last updated Aug 30, 2026 00:00 UTC
-
Could a cholesterol drug boost lung cancer treatment before surgery?
Disease control PausedThis study was originally opened on 10/22/2024 as an open-label, two-arm, randomized phase 2 clinical trial, patients with clinical stage 1B-3A non-small cell lung cancer (NSCLC) to receive neoadjuvant chemotherapy and cemiplimab every 3 weeks for 3 cycles with or without alirocu…
Phase 2 • Sponsor: Duke University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC